Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG for HCC Chemoprevention (CATCH-B)
NCT06015022Phase 2Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Sep 2024
- Primary completion
- Aug 2028
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epigallocatechin gallate in hepatocellular carcinoma (HCC), sponsored by UT Southwestern Medical Center. Started Sep 2024; status: recruiting.
02
Drugs
epigallocatechin gallate
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT06015022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06015022.